ANNOUNCER: A patient's blood may also be checked for antibodies often associated with rheumatoid arthritis.
ALISA KOCH, MD: These tests may include rheumatoid factor, which is an antibody. And it’s present in about 80 to 85% of patients. Over the last few years, there has been a second antibody that has come to the fore, which is also a good diagnostic marker for rheumatoid arthritis, and this antibody is called anti-citrullinated peptide, anti-CCP is how it’s commonly referred to. And it seems that anti-CCP is as good at picking up rheumatoid arthritis as rheumatoid factor. So it’s very important to have both the symptoms and signs, clinical symptoms and signs, as well as laboratory confirmation.
STEVEN ABRAMSON, MD: It’s very important that a person gets a diagnosis or an evaluation by a rheumatologist, because we have to be able to make that diagnosis even when the blood tests are negative so that we make the proper treatment decisions early, even in that first year of the disease.
ANNOUNCER: In spite of rheumatoid arthritis’ impact on patients’ lives, new treatment options are offering patients more control over their symptoms and a better quality of life.